Notice Number: NOT-DK-20-025
Key Dates
Release Date: April 28, 2020
PAR-18-857: Diet and Physical Activity Assessment Methodology (R21 Clinical Trial Not Allowed)
PAR-19-222: Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional)
NOT-DK-20-016: Notice of Early Expiration of NIDDK R21 Funding Opportunity Announcements
Issued by
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Cancer Institute (NCI)
Purpose
The purpose of this Notice is to amend NOT-DK-20-016 to reverse the early expiration of PAR-18-857 Diet and Physical Activity Assessment Methodology (R21 Clinical Trial Not Allowed) and PAR-19-222: Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional). NOT-DK-20-016 states that PAR-18-857 and PAR-19-222 will expire on September 8, 2020. This Notice restores the original Key Dates for PAR-18-857 which will expire on September 8, 2021; and for PAR-19-222 which will expire on May 8, 2021.
Key Dates for PAR-18-857 Diet and Physical Activity Assessment Methodology (R21 Clinical Trial Not Allowed)
Open Date (Earliest Submission Date): September 16, 2018
Letter of Intent Due Date(s): Not Applicable
Application Due Date(s): Standard dates apply. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Application Due Date(s): Standard AIDS dates apply by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Scientific Merit Review: Standard dates apply
Advisory Council Review: Standard dates apply
Earliest Start Date: Standard dates apply
Expiration Date: September 8, 2021
Key Dates for PAR-19-222: Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional)
Open Date (Earliest Submission Date): May 16, 2019
Letter of Intent Due Date(s): Not applicable
Application Due Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Application Due Date(s): Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Scientific Merit Review: Standard dates apply
Advisory Council Review: Standard dates apply
Earliest Start Date: Standard dates apply
Expiration Date: May 8, 2021
All other aspects of NOT-DK-20-016 remain unchanged.
Inquiries
Please direct all inquiries to:
For PAR-18-857:
Mary Evans, Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-594-4578
Email: evansmary@niddk.nih.gov
For PAR-19-222:
Katrina J. Serrano, Ph.D.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Telephone: 301-480-7855
Email: katrina.serrano@nih.gov
and Human Services (HHS)
